MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 263 filers reported holding MIRATI THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.48 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $209 | +95.3% | 4,805 | +63.2% | 0.00% | – |
Q2 2023 | $107 | +27.4% | 2,945 | +31.2% | 0.00% | – |
Q1 2023 | $84 | -13.4% | 2,244 | +5.7% | 0.00% | – |
Q4 2022 | $97 | -99.9% | 2,123 | +2.4% | 0.00% | – |
Q3 2022 | $145,000 | +5.8% | 2,074 | +1.6% | 0.00% | – |
Q2 2022 | $137,000 | -22.2% | 2,042 | +1.5% | 0.00% | – |
Q1 2022 | $176,000 | -41.7% | 2,012 | -2.6% | 0.00% | -100.0% |
Q4 2021 | $302,000 | -16.6% | 2,065 | +1.5% | 0.00% | 0.0% |
Q3 2021 | $362,000 | +10.0% | 2,035 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $329,000 | -13.0% | 2,035 | -8.4% | 0.00% | 0.0% |
Q1 2021 | $378,000 | -18.5% | 2,222 | +5.0% | 0.00% | 0.0% |
Q4 2020 | $464,000 | +32.2% | 2,117 | 0.0% | 0.00% | 0.0% |
Q3 2020 | $351,000 | +46.2% | 2,117 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $240,000 | +75.2% | 2,117 | +20.1% | 0.00% | – |
Q1 2020 | $137,000 | -39.4% | 1,763 | 0.0% | 0.00% | – |
Q4 2019 | $226,000 | -29.8% | 1,763 | -43.7% | 0.00% | -100.0% |
Q2 2019 | $322,000 | +40.6% | 3,130 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $229,000 | +182.7% | 3,130 | +58.0% | 0.00% | – |
Q4 2018 | $81,000 | -12.9% | 1,981 | 0.0% | 0.00% | – |
Q3 2018 | $93,000 | -4.1% | 1,981 | 0.0% | 0.00% | – |
Q2 2018 | $97,000 | – | 1,981 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |